ÂÜÀòÂÒÂ×

Eric Kudzinski is an accomplished professional in market access and training, currently serving as the Director of Market Access Training at Neurocrine Biosciences since October 2016. In this role, Eric develops and leads comprehensive training programs for various teams, contributing to significant expansions and new product launches in the rare disease space, as well as advanced Medicare training since 2018. Previously, Eric held positions including National Account Director at Neurocrine Biosciences, where successful partnerships were forged with major pharmacies and healthcare plans, and Corporate Account Director at Acorda Therapeutics, focusing on contract negotiations and client relationship development. Eric's career also includes key roles at Actavis plc, Daiichi Sankyo, and Bristol-Myers Squibb. Eric holds a Master's degree in Clinical Exercise Physiology from Indiana University Bloomington and a Bachelor's degree in Pre-Physical Therapy from Valparaiso University.